ey0018.8-3 | Important for Clinical Practice | ESPEYB18
DP Merke
, A Mallappa
, W Arlt
, A Brac de la Perriere
, A Linden Hirschberg
, A Juul
, J Newell-Price
, CG Perry
, A Prete
, DA Rees
, N Reisch
, N Stikkelbroeck
, P Touraine
, K Maltby
, FP Treasure
, J Porter
, RJ Ross
J Clin Endocrinol Metab 2021; 106(5): e2063e2077.https://pubmed.ncbi.nlm.nih.gov/33527139/The authors report the findings of a 6-month, randomized, phase 3 trial, with a single arm extension, to investigate the efficacy, safety and tolerability of modified release hydrocortisone (MC-HC) replacement therapy versus standard glucocorticoid replacement therapy in 122 adult patients with c...